Trial Profile
A phase IIa proof-of-principle study of oxytocin in normogonadotropic, oligozoospermic males
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary) ; Estrogen
- Indications Oligospermia
- Focus Proof of concept; Therapeutic Use
- 24 Nov 2015 According to the information on Pantarhei Bioscience website, the company plans to conduct a combined phase IIb/III study as a follow-up step after this study.
- 24 Nov 2015 New trial record